Skip to content
Menu

This Outlook Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor 3 hours ago

MarketsTrading IdeasPre-Market OutlookNewsAnalyst RatingsInitiation

Analysts initiated coverage: Anthropic (ANT) Buy/$150 and Outperform/$135; LASE Buy/$2; OTLK Overweight/$4; KINS Overweight/$24.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Considering buying OTLK stock? Here’s what analysts think:

Photo via Shutterstock

Read at benzinga.com